BRIEF COMMUNICATION
Patent ductus arteriosus (PDA) in low-birth-weight premature infants that causes large left-to-right shunts is associated with congestive heart failure, bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), intracranial hemorrhage, and death. [1] [2] [3] [4] For most preterm infants with PDA, the hemodynamic effects are not immediately lifethreatening and can be controlled medically without interventional ductus closure. Small preterm infants weighing < 1500 g at birth frequently have a prolonged course of ductus shunting, and characteristically require days or weeks of mechanical ventilation. Surgical ligation of the PDA in these infants improves lung compliance, decreases duration of assisted ventilation, and increases nutritional utilization. 5, 6 Although PDA ligation is a definitive treatment, the optimal time to ligation in very-lowbirth-weight (< 1500 g) premature infants remains controversial. Early surgical ligation has been advocated as the optimal therapy for PDA because it ensures definitive ductal closure with minimal morbidity and mortality. 2, 7 However, some studies have shown that PDA closure does not significantly influence outcome. [8] [9] [10] We performed a retrospective study to compare the efficacy and side effects between early and late ligation of symptomatic PDA.
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Methods

Patients
We retrospectively reviewed the charts of all premature infants with birth weight < 1500 g admitted between 1 January 2001 and 31 December 2003 to the neonatal intensive care unit (NICU) at the Children's Hospital of New York-Presbyterian (CHONY). The Institutional Review Board for human subject research approved the chart review. We excluded patients transferred from other hospitals, and those with major congenital anomalies and complex congenital heart disease (CHD). 
Inclusion criteria
Procedure
The premature infants with symptomatic PDA refractory to or contraindicated for medical closure, who underwent surgical ligation, were our target population. They were divided into two groups: early ligation (EL; age ≤ 14 days) and late ligation (LL; age > 14 days). The groups were compared with regard to gestational age, birth weight, Apgar score, antenatal steroids, respiratory distress syndrome (RDS), surfactant use, mean airway pressure, first day of symptomatic PDA, and mean age at surgery (Table 1) . Outcome assessed included BPD (defined as need for oxygen or respiratory support at 36 weeks of postconceptual age), grade III and IV intraventricular hemorrhage (IVH), stage 3 and 4 retinopathy of prematurity (ROP), NEC, acute renal failure (ARF; creatinine > 1.7 mg/dL), pneumothorax and mortality (Table 2 ). Nasal continuous positive airway pressure (CPAP), ventilator use, duration of total parenteral nutrition (TPN), and length of hospital stay were compared.
Statistical analysis
Statistical analysis was performed using a twotailed Student's t test for continuous variables and Fisher's two-tailed exact test for dichotomous variables. Continuous variables were reported as mean ± standard deviation. A value of p < 0.05 was considered significant.
Results
A total of 448 infants with < 1500 g body weight were born at CHONY and admitted to the NICU between 1 January 2001 and 31 December 2003. Thirty-two infants who had major congenital anomalies or complex CHD were excluded. A total of 167 cases (40.1%) developed symptomatic PDA, and 111 infants (66.5%) were successfully closed by medical treatment, which was confirmed by Doppler ultrasonography. A total of 56 cases (33.5%) underwent surgical ligation of symptomatic PDA, and were divided into the EL (age ≤ 14 days, n = 13) and LL (age > 14 days, n = 43) groups (Figure 1) . The gestational age of the study infants was 23-31 weeks and birth weight was 430-1310 g. There were no significant differences between the groups for gestational age, birth weight, APGAR score, antenatal steroid use, RDS, surfactant use, and mean airway pressure. The significant differences were first days of symptomatic PDA and mean age at surgery ( Table 1 ). The two groups were clinically similar and cared for in the same fashion.
Major morbidity and mortality are summarized in Table 2 . Patient outcomes were similar. BPD requiring oxygen therapy beyond 36 weeks postconceptual age occurred in two surviving infants in the EL group and 10 in the LL group (p = 1.000). NEC was noted in one infant in the EL group and in eight patients in the LL group, although this was not a significant difference (p = 0.670). Two infants in the EL and seven in the LL group died, but the difference was not significant (p = 1.00). Other morbidities that were common in premature infants, including ARF, grade III and IV IVH, stage 3 and 4 ROP, and pneumothorax, did not differ significantly between the two groups.
The EL group received nasal CPAP for 59.4 ± 25.6 days, similar to the 63.2 ± 28.4 days in the LL group (p = 0.668). The EL group received mechanical ventilation for 11.1 ± 6.7 days, which was significantly shorter than the 18.6 ± 10.5 days in the LL group (p = 0.019). The EL group received TPN for 39.6 ± 13.9 days, which was significantly shorter than the 60.4 ± 31.4 days in the LL group (p = 0.025). The mean length of hospital stay in the EL group was 92.3 ± 47.1 days, which did not 
Discussion
Our results indicated that the days of ventilator use and duration of TPN use were significantly shorter in premature infants with early surgical ligation (age ≤ 14 days) of symptomatic PDA that was refractory to medical treatment. We found no evidence that delayed duct closure was associated with BPD, NEC, IVH, ARF, ROP, length of hospital stay, or death.
The patency of the ductus arteriosus makes a "diastolic steal" of blood flow from the abdominal organs to the pulmonary artery and causes impaired intestinal blood flow. 11 Cassady et al confirmed that impaired intestinal blood flow may cause feeding intolerance and NEC in premature infants, and that early prophylactic ligation of PDA in extremely-low-birth-weight infants reduces the incidence of NEC. 12 This can explain why early ligation of PDA led to a shorter duration of TPN use and was able to meet most of the patients' nutritional needs at an earlier age, as well as sparing certain serious complications of TPN.
Jaillard et al have also shown that early surgical closure of the ductus arteriosus (< 3 weeks old) is associated with a shorter delay in full oral feeding and improved body growth, when compared with late surgical closure (> 3 weeks old). 5 NEC occurred in one of 13 infants in our EL group, but was noted in eight of 43 infants in the LL group. Early ligation of symptomatic PDA seemed to have a trend towards reducing NEC, but did not make a significant difference in our study. We found that infants in the EL group had fewer days of mechanical ventilation (11.1 ± 6.7 days vs. 18.6 ± 10.5 days in LL, p = 0.019), but BPD incidence did not differ. Early ligation of PDA improves pulmonary edema in premature infants, 13 proposed that any therapeutic regimen should be instituted very early to have any effect on reducing the development of BPD. The results of this study provide a rational solution to an important management dilemma. Even though CHF and pulmonary edema is satisfactorily controlled, we believe that the infant with symptomatic PDA who has failed treatment with indomethacin will benefit from early surgical closure of the ductus. The incidence of surgical complications in the present study was minimal and consistent with the 4-10% morbidity reported in the literature. 11, 17 Any infants with progressive, uncontrolled CHF or pulmonary edema should undergo immediate ductus closure as a lifesaving measure, unless the shunting in the ductus is right-to-left or bidirectional.
Our study was not a randomized controlled trial. The number of subjects was limited by the fact that the occurrence of symptomatic PDA in very-low-birth-weight infants refractory to medical closure was infrequent, and patients transferred from or referred to other hospitals were excluded because of follow-up difficulties and possible differences in treatment strategy. The long-term outcomes of PDA ligation were not followed in our study. Kabra et al reported that surgical PDA closure was a risk factor for neurosensory impairment at 18 months in children who were enrolled in the
Trial of Indomethacin Prophylaxis in Preterms.
18 Controlled trials with long-term follow-up are urgently needed to better delineate the role of surgical closure of PDA in the care of premature infants.
In conclusion, early ligation of medical refractory PDA in very-low-birth-weight premature infants improves enteral feeding tolerance and reduces TPN and ventilator use, but it does not improve the major outcomes of premature infants. The long-term benefits or harms need to be further evaluated.
